Skip to main content
Clinical Trials/NCT02878187
NCT02878187
Completed
Not Applicable

Evaluation of the Uterine Cavity and Blood Flow After Conservative Management of Placenta Previa/Accreta

Assiut University1 site in 1 country100 target enrollmentJanuary 15, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Improving Quality of Life
Sponsor
Assiut University
Enrollment
100
Locations
1
Primary Endpoint
The mean difference in the uterine arteries diameters in both groups
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Bleeding is the most significant cause of maternal death worldwide with more than half of those occurring within the first day of delivery. About 10.5% (some estimate as high at 12-17%) of live births world-wide, or about 14 million births, are complicated by postpartum hemorrhage; a woman dies every 4 minutes from postpartum hemorrhage. Uterine atony and placenta accreta are the two leading causes of postpartum hysterectomies with up to 64% of Cesarean hysterectomies done for abnormally adherent placentation

Detailed Description

No previous studies performed for evaluation of the effect of those procedures on the uterine cavity or uterine blood flow. Most of the studies in the literature evaluated the menstrual and fertility outcome after conservative measures for intraoperative hemorrhage due to placenta previa/accreta were retrospective and depend on the resumption of menses and pregnancy rate

Registry
clinicaltrials.gov
Start Date
January 15, 2017
End Date
May 2020
Last Updated
5 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ahmed Mohamed Abbas

Dr

Assiut University

Eligibility Criteria

Inclusion Criteria

  • Women Age 18-40 years
  • Gestational age of pregnancy 28-40 weeks
  • Diagnosed antenatally as placenta previa/accreta
  • Patients who will be managed by conservative surgical techniques for intraoperative hemorrhage
  • Women who will accept to participate in the study and are reliable for follow-up

Exclusion Criteria

  • 1- Patients who will be managed by hysterectomy 2- Patients who will be managed by conservative leaving the placenta in-situ 3- Diabetic or hypertensive women 4- Women who will refuse to participate in the study

Outcomes

Primary Outcomes

The mean difference in the uterine arteries diameters in both groups

Time Frame: 3 months

Study Sites (1)

Loading locations...

Similar Trials